Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 2,218: | Line 2,218: | ||
==WHO Central Nervous System Tumours (5th ed.) Content== | ==WHO Central Nervous System Tumours (5th ed.) Content== | ||
| class="wikitable" | |||
|- | |- | ||
!'''Disease'''!!'''Page Type'''!!'''Author''' | !'''Disease'''!!'''Page Type'''!!'''Author''' | ||
| Line 2,227: | Line 2,227: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
|- | |-|Astrocytoma, IDH-mutant||Disease|| | ||
| Astrocytoma, IDH-mutant||Disease|| | |||
| | | | ||
| | | | ||
| Line 2,237: | Line 2,236: | ||
| | | | ||
|- | |- | ||
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,246: | Line 2,245: | ||
| | | | ||
|- | |- | ||
| Glioblastoma, IDH-wildtype||Disease|| | |Glioblastoma, IDH-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,255: | Line 2,254: | ||
| | | | ||
|- | |- | ||
| Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,264: | Line 2,263: | ||
| | | | ||
|- | |- | ||
| Angiocentric glioma||Disease|| | |Angiocentric glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,273: | Line 2,272: | ||
| | | | ||
|- | |- | ||
| Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,282: | Line 2,281: | ||
| | | | ||
|- | |- | ||
| Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| | |Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,291: | Line 2,290: | ||
| | | | ||
|- | |- | ||
| Diffuse midline glioma, H3 K27-altered||Disease|| | |Diffuse midline glioma, H3 K27-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,300: | Line 2,299: | ||
| | | | ||
|- | |- | ||
| Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,309: | Line 2,308: | ||
| | | | ||
|- | |- | ||
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,318: | Line 2,317: | ||
| | | | ||
|- | |- | ||
| Infant-type hemispheric glioma||Disease|| | |Infant-type hemispheric glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,327: | Line 2,326: | ||
| | | | ||
|- | |- | ||
| Pilocytic astrocytoma ||Disease|| | |Pilocytic astrocytoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,336: | Line 2,335: | ||
| | | | ||
|- | |- | ||
| High-grade astrocytoma with piloid features||Disease|| | |High-grade astrocytoma with piloid features||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,345: | Line 2,344: | ||
| | | | ||
|- | |- | ||
| Pleomorphic xanthoastrocytoma||Disease|| | |Pleomorphic xanthoastrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,354: | Line 2,353: | ||
| | | | ||
|- | |- | ||
| Subependymal giant cell astrocytoma||Disease|| | |Subependymal giant cell astrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,363: | Line 2,362: | ||
| | | | ||
|- | |- | ||
| Chordoid glioma||Disease|| | |Chordoid glioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,372: | Line 2,371: | ||
| | | | ||
|- | |- | ||
| Astroblastoma, MN1-altered||Disease|| | |Astroblastoma, MN1-altered||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,381: | Line 2,380: | ||
| | | | ||
|- | |- | ||
| Ganglioglioma||Disease|| | |Ganglioglioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,390: | Line 2,389: | ||
| | | | ||
|- | |- | ||
| Gangliocytoma||Disease|| | |Gangliocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,399: | Line 2,398: | ||
| | | | ||
|- | |- | ||
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,408: | Line 2,407: | ||
| | | | ||
|- | |- | ||
| Dysembryoplastic neuroepithelial tumour||Disease|| | |Dysembryoplastic neuroepithelial tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,417: | Line 2,416: | ||
| | | | ||
|- | |- | ||
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,426: | Line 2,425: | ||
| | | | ||
|- | |- | ||
| Papillary glioneuronal tumour||Disease|| | |Papillary glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,435: | Line 2,434: | ||
| | | | ||
|- | |- | ||
| Rosette-forming glioneuronal tumour||Disease|| | |Rosette-forming glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,444: | Line 2,443: | ||
| | | | ||
|- | |- | ||
| Myxoid glioneuronal tumour||Disease|| | |Myxoid glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,453: | Line 2,452: | ||
| | | | ||
|- | |- | ||
| Diffuse leptomeningeal glioneuronal tumour||Disease|| | |Diffuse leptomeningeal glioneuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,462: | Line 2,461: | ||
| | | | ||
|- | |- | ||
| Multinodular and vacuolating neuronal tumour||Disease|| | |Multinodular and vacuolating neuronal tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,471: | Line 2,470: | ||
| | | | ||
|- | |- | ||
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,480: | Line 2,479: | ||
| | | | ||
|- | |- | ||
| Central neurocytoma||Disease|| | |Central neurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,489: | Line 2,488: | ||
| | | | ||
|- | |- | ||
| Extraventricular neurocytoma||Disease|| | |Extraventricular neurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,498: | Line 2,497: | ||
| | | | ||
|- | |- | ||
| Cerebellar liponeurocytoma||Disease|| | |Cerebellar liponeurocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,507: | Line 2,506: | ||
| | | | ||
|- | |- | ||
| Supratentorial ependymoma||Disease|| | |Supratentorial ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,516: | Line 2,515: | ||
| | | | ||
|- | |- | ||
| Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| | |Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,525: | Line 2,524: | ||
| | | | ||
|- | |- | ||
| Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,534: | Line 2,533: | ||
| | | | ||
|- | |- | ||
| Posterior fossa ependymoma||Disease|| | |Posterior fossa ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,543: | Line 2,542: | ||
| | | | ||
|- | |- | ||
| Posterior fossa group A (PFA) ependymoma||Disease|| | |Posterior fossa group A (PFA) ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,552: | Line 2,551: | ||
| | | | ||
|- | |- | ||
| Posterior fossa group B (PFB) ependymoma||Disease|| | |Posterior fossa group B (PFB) ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,561: | Line 2,560: | ||
| | | | ||
|- | |- | ||
| Spinal ependymoma||Disease|| | |Spinal ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,570: | Line 2,569: | ||
| | | | ||
|- | |- | ||
| Spinal ependymoma, MYCN-amplified||Disease|| | |Spinal ependymoma, MYCN-amplified||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,579: | Line 2,578: | ||
| | | | ||
|- | |- | ||
| Myxopapillary ependymoma||Disease|| | |Myxopapillary ependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,588: | Line 2,587: | ||
| | | | ||
|- | |- | ||
| Subependymoma||Disease|| | |Subependymoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,597: | Line 2,596: | ||
| | | | ||
|- | |- | ||
| Choroid plexus papilloma||Disease|| | |Choroid plexus papilloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,606: | Line 2,605: | ||
| | | | ||
|- | |- | ||
| Atypical choroid plexus papilloma||Disease|| | |Atypical choroid plexus papilloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,615: | Line 2,614: | ||
| | | | ||
|- | |- | ||
| Choroid plexus carcinoma||Disease|| | |Choroid plexus carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,624: | Line 2,623: | ||
| | | | ||
|- | |- | ||
| Medulloblastoma, WNT-activated||Disease|| | |Medulloblastoma, WNT-activated||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,633: | Line 2,632: | ||
| | | | ||
|- | |- | ||
| Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,642: | Line 2,641: | ||
| | | | ||
|- | |- | ||
| Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,651: | Line 2,650: | ||
| | | | ||
|- | |- | ||
| Medulloblastoma, non-WNT/non-SHH||Disease|| | |Medulloblastoma, non-WNT/non-SHH||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,660: | Line 2,659: | ||
| | | | ||
|- | |- | ||
| Medulloblastoma, histologically defined||Disease|| | |Medulloblastoma, histologically defined||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,669: | Line 2,668: | ||
| | | | ||
|- | |- | ||
| Atypical teratoid/rhabdoid tumour||Disease|| | |Atypical teratoid/rhabdoid tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,678: | Line 2,677: | ||
| | | | ||
|- | |- | ||
| Cribriform neuroepithelial tumour||Disease|| | |Cribriform neuroepithelial tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,687: | Line 2,686: | ||
| | | | ||
|- | |- | ||
| Embryonal tumour with multilayered rosettes||Disease|| | |Embryonal tumour with multilayered rosettes||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,696: | Line 2,695: | ||
| | | | ||
|- | |- | ||
| CNS neuroblastoma, FOXR2-activated||Disease|| | |CNS neuroblastoma, FOXR2-activated||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,705: | Line 2,704: | ||
| | | | ||
|- | |- | ||
| CNS tumour with BCOR internal tandem duplication||Disease|| | |CNS tumour with BCOR internal tandem duplication||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,714: | Line 2,713: | ||
| | | | ||
|- | |- | ||
| CNS embryonal tumour NEC/NOS||Disease|| | |CNS embryonal tumour NEC/NOS||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,723: | Line 2,722: | ||
| | | | ||
|- | |- | ||
| Pineocytoma||Disease|| | |Pineocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,732: | Line 2,731: | ||
| | | | ||
|- | |- | ||
| Pineal parenchymal tumour of intermediate differentiation||Disease|| | |Pineal parenchymal tumour of intermediate differentiation||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,741: | Line 2,740: | ||
| | | | ||
|- | |- | ||
| Pineoblastoma||Disease|| | |Pineoblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,750: | Line 2,749: | ||
| | | | ||
|- | |- | ||
| Papillary tumour of the pineal region||Disease|| | |Papillary tumour of the pineal region||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,759: | Line 2,758: | ||
| | | | ||
|- | |- | ||
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,768: | Line 2,767: | ||
| | | | ||
|- | |- | ||
| Schwannoma||Disease|| | |Schwannoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,777: | Line 2,776: | ||
| | | | ||
|- | |- | ||
| Neurofibroma||Disease|| | |Neurofibroma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,786: | Line 2,785: | ||
| | | | ||
|- | |- | ||
| Perineurioma||Disease|| | |Perineurioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,795: | Line 2,794: | ||
| | | | ||
|- | |- | ||
| Hybrid nerve sheath tumours||Disease|| | |Hybrid nerve sheath tumours||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,804: | Line 2,803: | ||
| | | | ||
|- | |- | ||
| Malignant melanotic nerve sheath tumour||Disease|| | |Malignant melanotic nerve sheath tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,813: | Line 2,812: | ||
| | | | ||
|- | |- | ||
| Malignant peripheral nerve sheath tumour||Disease|| | |Malignant peripheral nerve sheath tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,822: | Line 2,821: | ||
| | | | ||
|- | |- | ||
| Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,831: | Line 2,830: | ||
| | | | ||
|- | |- | ||
| Meningioma||Disease|| | |Meningioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,840: | Line 2,839: | ||
| | | | ||
|- | |- | ||
| Solitary fibrous tumour||Disease|| | |Solitary fibrous tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,849: | Line 2,848: | ||
| | | | ||
|- | |- | ||
| Haemangiomas and vascular malformations||Disease|| | |Haemangiomas and vascular malformations||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,858: | Line 2,857: | ||
| | | | ||
|- | |- | ||
| Haemangioblastoma||Disease|| | |Haemangioblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,867: | Line 2,866: | ||
| | | | ||
|- | |- | ||
| Rhabdomyosarcoma||Disease|| | |Rhabdomyosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,876: | Line 2,875: | ||
| | | | ||
|- | |- | ||
| Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,885: | Line 2,884: | ||
| | | | ||
|- | |- | ||
| CIC-rearranged sarcoma||Disease|| | |CIC-rearranged sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,894: | Line 2,893: | ||
| | | | ||
|- | |- | ||
| Primary intracranial sarcoma, DICER1-mutant||Disease|| | |Primary intracranial sarcoma, DICER1-mutant||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,903: | Line 2,902: | ||
| | | | ||
|- | |- | ||
| Ewing sarcoma||Disease|| | |Ewing sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,912: | Line 2,911: | ||
| | | | ||
|- | |- | ||
| Mesenchymal chondrosarcoma||Disease|| | |Mesenchymal chondrosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,921: | Line 2,920: | ||
| | | | ||
|- | |- | ||
| Chondrosarcoma||Disease|| | |Chondrosarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,930: | Line 2,929: | ||
| | | | ||
|- | |- | ||
| Chordoma||Disease|| | |Chordoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,939: | Line 2,938: | ||
| | | | ||
|- | |- | ||
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,948: | Line 2,947: | ||
| | | | ||
|- | |- | ||
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,957: | Line 2,956: | ||
| | | | ||
|- | |- | ||
| Primary diffuse large B-cell lymphoma of the CNS||Disease|| | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,966: | Line 2,965: | ||
| | | | ||
|- | |- | ||
| Immunodeficiency-associated CNS lymphomas||Disease|| | |Immunodeficiency-associated CNS lymphomas||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,975: | Line 2,974: | ||
| | | | ||
|- | |- | ||
| Lymphomatoid granulomatosis||Disease|| | |Lymphomatoid granulomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,984: | Line 2,983: | ||
| | | | ||
|- | |- | ||
| Intravascular large B-cell lymphoma||Disease|| | |Intravascular large B-cell lymphoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 2,993: | Line 2,992: | ||
| | | | ||
|- | |- | ||
| MALT lymphoma of the dura||Disease|| | |MALT lymphoma of the dura||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,002: | Line 3,001: | ||
| | | | ||
|- | |- | ||
| Other low-grade B-cell lymphomas of the CNS||Disease|| | |Other low-grade B-cell lymphomas of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,011: | Line 3,010: | ||
| | | | ||
|- | |- | ||
| Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,020: | Line 3,019: | ||
| | | | ||
|- | |- | ||
| T-cell and NK/T-cell lymphomas||Disease|| | |T-cell and NK/T-cell lymphomas||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,029: | Line 3,028: | ||
| | | | ||
|- | |- | ||
| Erdheim-Chester disease||Disease|| | |Erdheim-Chester disease||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,038: | Line 3,037: | ||
| | | | ||
|- | |- | ||
| Rosai-Dorfman disease||Disease|| | |Rosai-Dorfman disease||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,047: | Line 3,046: | ||
| | | | ||
|- | |- | ||
| Juvenile xanthogranuloma||Disease|| | |Juvenile xanthogranuloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,056: | Line 3,055: | ||
| | | | ||
|- | |- | ||
| Langerhans cell histiocytosis||Disease|| | |Langerhans cell histiocytosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,065: | Line 3,064: | ||
| | | | ||
|- | |- | ||
| Histiocytic sarcoma||Disease|| | |Histiocytic sarcoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,074: | Line 3,073: | ||
| | | | ||
|- | |- | ||
| Germ cell tumours of the CNS||Disease|| | |Germ cell tumours of the CNS||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,083: | Line 3,082: | ||
| | | | ||
|- | |- | ||
| Adamantinomatous craniopharyngioma||Disease|| | |Adamantinomatous craniopharyngioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,092: | Line 3,091: | ||
| | | | ||
|- | |- | ||
| Papillary craniopharyngioma||Disease|| | |Papillary craniopharyngioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,101: | Line 3,100: | ||
| | | | ||
|- | |- | ||
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,110: | Line 3,109: | ||
| | | | ||
|- | |- | ||
| Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,119: | Line 3,118: | ||
| | | | ||
|- | |- | ||
| Pituitary blastoma||Disease|| | |Pituitary blastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,128: | Line 3,127: | ||
| | | | ||
|- | |- | ||
| Metastases to the brain and spinal cord parenchyma||Disease|| | |Metastases to the brain and spinal cord parenchyma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,137: | Line 3,136: | ||
| | | | ||
|- | |- | ||
| Metastases to the meninges||Disease|| | |Metastases to the meninges||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,146: | Line 3,145: | ||
| | | | ||
|- | |- | ||
| Neurofibromatosis type 1||Disease|| | |Neurofibromatosis type 1||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,155: | Line 3,154: | ||
| | | | ||
|- | |- | ||
| Neurofibromatosis type 2||Disease|| | |Neurofibromatosis type 2||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,164: | Line 3,163: | ||
| | | | ||
|- | |- | ||
| Schwannomatosis||Disease|| | |Schwannomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,173: | Line 3,172: | ||
| | | | ||
|- | |- | ||
| Von Hippel-Lindau syndrome||Disease|| | |Von Hippel-Lindau syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,182: | Line 3,181: | ||
| | | | ||
|- | |- | ||
| Tuberous sclerosis||Disease|| | |Tuberous sclerosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,191: | Line 3,190: | ||
| | | | ||
|- | |- | ||
| Li-Fraumeni syndrome||Disease|| | |Li-Fraumeni syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,200: | Line 3,199: | ||
| | | | ||
|- | |- | ||
| Cowden syndrome||Disease|| | |Cowden syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,209: | Line 3,208: | ||
| | | | ||
|- | |- | ||
| Constitutional mismatch repair deficiency syndrome||Disease|| | |Constitutional mismatch repair deficiency syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,218: | Line 3,217: | ||
| | | | ||
|- | |- | ||
| Familial adenomatous polyposis 1||Disease|| | |Familial adenomatous polyposis 1||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,227: | Line 3,226: | ||
| | | | ||
|- | |- | ||
| Naevoid basal cell carcinoma syndrome||Disease|| | |Naevoid basal cell carcinoma syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,236: | Line 3,235: | ||
| | | | ||
|- | |- | ||
| Rhabdoid tumour predisposition syndrome||Disease|| | |Rhabdoid tumour predisposition syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,245: | Line 3,244: | ||
| | | | ||
|- | |- | ||
| Carney complex||Disease|| | |Carney complex||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,254: | Line 3,253: | ||
| | | | ||
|- | |- | ||
| DICER1 syndrome||Disease|| | |DICER1 syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,263: | Line 3,262: | ||
| | | | ||
|- | |- | ||
| Familial paraganglioma syndromes||Disease|| | |Familial paraganglioma syndromes||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,272: | Line 3,271: | ||
| | | | ||
|- | |- | ||
| Melanoma-astrocytoma syndrome||Disease|| | |Melanoma-astrocytoma syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,281: | Line 3,280: | ||
| | | | ||
|- | |- | ||
| Familial retinoblastoma||Disease|| | |Familial retinoblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,290: | Line 3,289: | ||
| | | | ||
|- | |- | ||
| BAP1 tumour predisposition syndrome||Disease|| | |BAP1 tumour predisposition syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,299: | Line 3,298: | ||
| | | | ||
|- | |- | ||
| Fanconi anaemia||Disease|| | |Fanconi anaemia||Disease|| | ||
| | | | ||
| | | | ||
| Line 3,308: | Line 3,307: | ||
| | | | ||
|- | |- | ||
| ELP1-medulloblastoma syndrome||Disease|| | |ELP1-medulloblastoma syndrome||Disease|| | ||
| | | | ||
| | | | ||